{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T13:06:10Z","timestamp":1794143170534,"version":"4.8.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"\n Importance<\/jats:title>\n Hypertension underpins significant global morbidity and mortality. Early lifestyle intervention and treatment are effective in reducing adverse outcomes. Artificial intelligence\u2013enhanced electrocardiography (AI-ECG) has been shown to identify a broad spectrum of subclinical disease and may be useful for predicting incident hypertension.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To develop an AI-ECG risk estimator (AIRE) to predict incident hypertension (AIRE-HTN) and stratify risk for hypertension-associated adverse outcomes.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This was a development and external validation prognostic cohort study conducted at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts, a secondary care setting. External validation was conducted in the UK Biobank (UKB), a UK-based volunteer cohort. AIRE-HTN was trained and tested to predict incident hypertension using routinely collected ECGs from patients at BIDMC between 2014 and 2023. The algorithm was then evaluated to risk stratify patients for hypertension- associated adverse outcomes and externally validated on UKB data between 2014 and 2022 for both incident hypertension and risk stratification<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n AIRE-HTN, which uses a residual convolutional neural network architecture with a discrete-time survival loss function, was trained to predict incident hypertension.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n AIRE-HTN was trained on 1\u202f163\u202f401 ECGs from 189\u202f539 patients (mean [SD] age, 57.7 [18.7] years; 98\u202f747 female [52.1%]) at BIDMC. A total of 19\u202f423 BIDMC patients composed the test set and were evaluated for incident hypertension. From the UKB, AIRE-HTN was tested on 65\u202f610 ECGs from same number of participants (mean [SD] age, 65.4 [7.9] years; 33\u202f785 female [51.5%]). A total of 35\u202f806 UKB patients were evaluated for incident hypertension. AIRE-HTN predicted incident hypertension (BIDMC: n\u2009=\u20096446 [33%] events; C index, 0.70; 95% CI, 0.69-0.71; UKB: n\u2009=\u20091532 [4%] events; C index, 0.70; 95% CI, 0.69-0.71). Performance was maintained in individuals without left ventricular hypertrophy and those with normal ECGs (C indices, 0.67-0.72). AIRE-HTN was significantly additive to existing clinical risk factors in predicting incident hypertension (continuous net reclassification index, BIDMC: 0.44; 95% CI, 0.33-0.53; UKB: 0.32; 95% CI, 0.23-0.37). In adjusted Cox models, AIRE-HTN score was an independent predictor of cardiovascular death (hazard ratio [HR] per standard deviation, 2.24; 95% CI, 1.67-3.00) and stratified risk for heart failure (HR, 2.60; 95% CI, 2.22-3.04), myocardial infarction (HR, 3.13; 95% CI, 2.55-3.83), ischemic stroke (HR, 1.23; 95% CI, 1.11-1.37), and chronic kidney disease (HR, 1.89; 95% CI, 1.68-2.12), beyond traditional risk factors.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Results suggest that AIRE-HTN, an AI-ECG model, can predict incident hypertension and identify patients at risk of hypertension-related adverse events, beyond conventional clinical risk factors.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamacardio.2024.4796","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T11:01:14Z","timestamp":1735815674000},"page":"214","source":"Crossref","is-referenced-by-count":29,"title":["Artificial Intelligence\u2013Enhanced Electrocardiography for Prediction of Incident Hypertension"],"prefix":"10.1001","volume":"10","author":[{"given":"Arunashis","family":"Sau","sequence":"first","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, United Kingdom"},{"name":"Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Barker","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libor","family":"Pastika","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Sieliwonczyk","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, United Kingdom"},{"name":"MRC Laboratory of Medical Sciences, Imperial College London, London, United Kingdom"},{"name":"University of Antwerp and Antwerp University Hospital, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Patlatzoglou","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"McGurk","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, United Kingdom"},{"name":"MRC Laboratory of Medical Sciences, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S.","family":"Peters","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, United Kingdom"},{"name":"Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan P.","family":"O\u2019Regan","sequence":"additional","affiliation":[{"name":"MRC Laboratory of Medical Sciences, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Ware","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, United Kingdom"},{"name":"Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom"},{"name":"MRC Laboratory of Medical Sciences, Imperial College London, London, United Kingdom"},{"name":"Department of Cardiology, Royal Brompton & Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Kramer","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, United Kingdom"},{"name":"Richard A. & Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Waks","sequence":"additional","affiliation":[{"name":"Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu Siong","family":"Ng","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, United Kingdom"},{"name":"Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom"},{"name":"Department of Cardiology, Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"11","key":"hoi240080r3","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jacc.2018.07.008","article-title":"Prevention and control of hypertension: JACC health promotion series.","volume":"72","author":"Carey","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"33","key":"hoi240080r4","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension.","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"hoi240080r5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/01.CIR.97.1.48","article-title":"Prognostic significance of serial changes in left ventricular mass in essential hypertension.","volume":"97","author":"Verdecchia","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"hoi240080r7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/ehjdh\/ztae004","article-title":"Artificial intelligence for ventricular arrhythmia capability using ambulatory electrocardiograms.","volume":"5","author":"Barker","year":"2024","journal-title":"Eur Heart J Digit Health"},{"issue":"11","key":"hoi240080r8","doi-asserted-by":"publisher","first-page":"e791","DOI":"10.1016\/S2589-7500(24)00172-9","article-title":"Artificial intelligence\u2013enabled electrocardiogram for mortality and cardiovascular risk estimation: a model development and validity study.","volume":"6","author":"Sau","year":"2024","journal-title":"Lancet Digit Health"},{"key":"hoi240080r9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.123.010602","article-title":"Prognostic significance and associations of neural network\u2013derived electrocardiographic features.","author":"Sau","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"hoi240080r10","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1038\/s41467-020-15432-4","article-title":"Automatic diagnosis of the 12-lead ECG using a deep neural network.","volume":"11","author":"Ribeiro","year":"2020","journal-title":"Nat Commun"},{"key":"hoi240080r11","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6257","article-title":"A scalable discrete-time survival model for neural networks.","volume":"7","author":"Gensheimer","year":"2019","journal-title":"PeerJ"},{"key":"hoi240080r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2023.107798","article-title":"BRAVEHEART: open-source software for automated electrocardiographic and vectorcardiographic analysis.","volume":"242","author":"Stabenau","year":"2023","journal-title":"Comput Methods Programs Biomed"},{"issue":"3","key":"hoi240080r13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"hoi240080r14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0002-8703(49)90562-1","article-title":"The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads.","volume":"37","author":"Sokolow","year":"1949","journal-title":"Am Heart J"},{"issue":"8","key":"hoi240080r15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/00365510600892233","article-title":"Evaluation of left ventricular mass measured by 3-D echocardiography using magnetic resonance imaging as gold standard.","volume":"66","author":"Lenstrup","year":"2006","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"hoi240080r16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/10976640600572889","article-title":"Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance.","volume":"8","author":"Maceira","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"issue":"5","key":"hoi240080r17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v059.i05","article-title":"Mediation: R package for causal mediation analysis.","volume":"59","author":"Tingley","year":"2014","journal-title":"J Stat Softw"},{"key":"hoi240080r18","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5714454","article-title":"Machine learning and electrocardiography signal-based minimum calculation time detection for blood pressure detection.","volume":"2022","author":"Nour","year":"2022","journal-title":"Comput Math Methods Med"},{"issue":"2","key":"hoi240080r19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cvdhj.2023.03.001","article-title":"Artificial intelligence-enabled classification of hypertrophic heart diseases using electrocardiograms.","volume":"4","author":"Haimovich","year":"2023","journal-title":"Cardiovasc Digit Health J"},{"key":"hoi240080r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpbup.2023.100097","article-title":"Interpretable hybrid model for an automated patientwise categorization of hypertensive and normotensive electrocardiogram signals.","volume":"3","author":"Chen","year":"2023","journal-title":"Comput Methods Programs Biomed Update"},{"issue":"3","key":"hoi240080r21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/ehjdh\/ztae014","article-title":"Decoding 2.3 million ECGs: interpretable deep learning for advancing cardiovascular diagnosis and mortality risk stratification.","volume":"5","author":"Lu","year":"2024","journal-title":"Eur Heart J Digit Health"},{"key":"hoi240080r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2020.103630","article-title":"A computational intelligence tool for the detection of hypertension using empirical mode decomposition.","volume":"118","author":"Soh","year":"2020","journal-title":"Comput Biol Med"},{"issue":"12","key":"hoi240080r23","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1097\/HJH.0000000000003286","article-title":"Artificial intelligence-based opportunistic screening for the detection of arterial hypertension through ECG signals.","volume":"40","author":"Angelaki","year":"2022","journal-title":"J Hypertens"},{"issue":"17","key":"hoi240080r24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003483","article-title":"Use of electrocardiography to predict future development of hypertension in the general population.","volume":"95","author":"Takase","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"9943","key":"hoi240080r25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data.","volume":"384","author":"Blood Pressure-Lowering Treatment Trialists\u2019 Collaboration","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"hoi240080r26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.7326\/0003-4819-159-3-201308060-00008","article-title":"Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis.","volume":"159","author":"Uhlig","year":"2013","journal-title":"Ann Intern Med"},{"key":"hoi240080r27","doi-asserted-by":"publisher","first-page":"f1325","DOI":"10.1136\/bmj.f1325","article-title":"Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomized trials.","volume":"346","author":"He","year":"2013","journal-title":"BMJ"},{"issue":"7","key":"hoi240080r28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7326\/0003-4819-136-7-200204020-00006","article-title":"Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials.","volume":"136","author":"Whelton","year":"2002","journal-title":"Ann Intern Med"},{"issue":"6","key":"hoi240080r29","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1067\/mhj.2000.111112","article-title":"Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension.","volume":"140","author":"Brown","year":"2000","journal-title":"Am Heart J"},{"issue":"20","key":"hoi240080r30","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1001\/archinte.162.20.2313","article-title":"Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension.","volume":"162","author":"Palatini","year":"2002","journal-title":"Arch Intern Med"},{"issue":"1","key":"hoi240080r31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/01.HYP.0000132556.91792.6a","article-title":"Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients.","volume":"44","author":"Okin","year":"2004","journal-title":"Hypertension"},{"issue":"5","key":"hoi240080r32","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1161\/01.HYP.0000125230.46080.c6","article-title":"QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study.","volume":"43","author":"Oikarinen","year":"2004","journal-title":"Hypertension"},{"issue":"4","key":"hoi240080r33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4103\/aam.aam_9_17","article-title":"Study of carotid intimal medial thickness in essential hypertension with or without left ventricular hypertrophy.","volume":"16","author":"Khutan","year":"2017","journal-title":"Ann Afr Med"},{"issue":"4","key":"hoi240080r34","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/HCO.0000000000000180","article-title":"Birth weight and arterial hypertension.","volume":"30","author":"Bruno","year":"2015","journal-title":"Curr Opin Cardiol"},{"issue":"2","key":"hoi240080r35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation.","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"9","key":"hoi240080r36","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population.","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"},{"key":"hoi240080r6","first-page":"101","volume-title":"Herinneringsbudendedl Professor S.S. Rosenstein","author":"Einthoven","year":"1902"},{"key":"hoi240080r1","unstructured":"Centers for Disease Control and Prevention. National Center for Health Statistics mortality data on CDC WONDER. Accessed February 2, 2023. https:\/\/wonder.cdc.gov\/mcd.html"},{"key":"hoi240080r2","unstructured":"World Health Organization. Global report on hypertension: the race against a silent killer. Accessed February 2, 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240081062"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2828420\/jamacardiology_sau_2025_oi_240080_1741367268.95218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:01:53Z","timestamp":1741777313000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2828420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2024.4796","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,1]]}}}